Revenue - Rollforward of Accounts Receivable (Details) $ in Thousands |
3 Months Ended |
|---|---|
|
Mar. 31, 2026
USD ($)
| |
| Accounts Receivable, After allowance for Credit Loss, Current [Roll Forward] | |
| Beginning balance at December 31, 2025 | $ 573 |
| Increase in accounts receivable for drug product sales | 2,852 |
| Decrease in accounts receivable for cash collections | (2,312) |
| Balance as of March 31, 2026 | $ 1,113 |